Champions Oncology CSBR 深 沪
已收盘 09-25 16:00:00 美东时间
4.90
-0.050
-1.01%
华盛通- 最 高4.955
- 今 开4.81
- 成交量 8796股
- 最 低 4.8001
- 昨 收 4.95
- 总市值 6820.10万
- 52周最高 8.3099
- 市盈率 静 --
- 换手率 0.06%
- 52周最低 4.59
- 委 比 -73.91%
- 总股本 1391.86万
- 历史最高 19.80
- 量 比 0.79
- 振 幅 3.13%
- 历史最低 1.11
- 每 手 1
- 风险率 0.62%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Full Transcript: Champions Oncology Q4 2026 Earnings Call
Champions Oncology (NASDAQ:CSBR) reported fourth-quarter financial results on Monday. The transcript from the company's fourth-quarter earnings call has been provided below. This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit https://www.benzi...
09-17 19:12
Champions Oncology Earnings Call Highlights Margin Momentum
Champions Oncology (($CSBR)) has held its Q1 earnings call. Read on for the mai...
09-12 08:12
Champions Oncology Q1 Adj. EPS $0.05 Up From $0.01 YoY, Sales $15.232M Up From $13.995M YoY
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.05 per share. This is a 400 percent increase over earnings of $0.01 per share from the same period last year. The company reported $15.232 million in sales this quarter. This is a 8.84 percent increase over sales of $13.995 million t...
09-11 04:26
Champions Oncology Expands Radiopharmaceutical Platform With In-House SPECT/CT Imaging For Integrated Tumor Biology And Efficacy Insights
New molecular imaging capabilities connect longitudinal radiopharmaceutical uptake with biodistribution, efficacy and clinically annotated PDX tumor biology in a single, U.S.-based workflow HACKENSACK, NJ / ACCESS Newswire / September 1, 2026 / Champions Oncology, Inc., a leading provider of transla...
09-01 21:05
Champions Oncology Earnings Call Highlights Growth, Risks
Champions Oncology (($CSBR)) has held its Q4 earnings call. Read on for the mai...
08-16 08:27
Champions Oncology Q4 Adj. EPS $0.01 Beats $(0.05) Estimate, Sales $13.835M Beat $12.886M Estimate
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.05) by 120 percent. This is a 114.29 percent increase over losses of $(0.07) per share from the same period last year. The company reported quarterly sales of $13.835 mill...
07-28 04:07
Champions Oncology Adds Director to Advance Data-Driven Strategy
The latest update is out from Champions Oncology ( ($CSBR) ). On March 24, 2026...
03-31 03:32
Champions Oncology Balances Record Services With Margin Strain
Champions Oncology (($CSBR)) has held its Q3 earnings call. Read on for the mai...
03-14 08:08
Champions Oncology Q3 Adj. EPS $0.04 Misses $0.09 Estimate, Sales $16.559M Miss $16.613M Estimate
Champions Oncology (NASDAQ:CSBR) reported quarterly earnings of $0.04 per share which missed the analyst consensus estimate of $0.09 by 55.56 percent. This is a 88.89 percent decrease over earnings of $0.36 per share
03-13 04:03
Earnings Scheduled For March 12, 2026
Companies Reporting Before The Bell • Seres Therapeutics (NASDAQ:MCRB) is likel...
03-12 19:11
